ALNY – alnylam pharmaceuticals, inc. (US:NASDAQ)

News

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its "outperform" rating re-affirmed by analysts at William Blair.
Biodefense Global Industry Overview 2021-2030: AI and Machine Learning to Revolutionize Early Detection and Response [Yahoo! Finance]
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $400.00 price target on the stock.
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $296.00 price target on the stock.
ALNY Reports Sustained 6-Month Efficacy Data From Amyloidosis Study [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com